Proven Strategies for Treating MDD in Patients Who Require Treatment Augmentation

Gain expert insights on augmentation strategies for patients with MDD who respond suboptimally to antidepressant therapy. Enter your patient case details in the MDD Interactive Decision Support Tool to see how the experts would proceed and review case-based discussion of current best practice in 3 Clinical Focus modules with downloadable slides.
Leslie Citrome, MD, MPH
Christoph U. Correll, MD
Rakesh Jain, MD, MPH
Roger McIntyre, MD, FRCPC
Michael E. Thase, MD

Modules

This concise CME-certified activity provides insights from an expert on how to implement guideline-based care for your patients with MDD who require treatment augmentation.

Roger McIntyre, MD, FRCPC Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: February 26, 2020 Expired: February 25, 2021

Gain insights from an expert on how to implement guideline-based care for your patients with MDD who require treatment augmentation.

Roger McIntyre, MD, FRCPC Released: February 26, 2020

Gain expert insights on identifying and managing common comorbidities in patients with MDD, including obesity, cardiovascular disease, and substance use disorder.

Christoph U. Correll, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 13, 2020 Expired: April 12, 2021

Gain expert insights on the importance of addressing comorbidities when caring for your patients with MDD who require treatment augmentation.

Christoph U. Correll, MD Released: April 13, 2020

Learn about the efficacy and role of second-generation antipsychotics for treatment augmentation in patients with MDD and learn how to mitigate and manage adverse events.

Rakesh Jain, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 7, 2020 Expired: May 6, 2021

See slides on the efficacy and role of second-generation antipsychotics for treatment augmentation in patients with MDD, and how to mitigate and manage adverse events.

Rakesh Jain, MD, MPH Released: May 7, 2020

Interactive Decision Support Tool

Expert recommendations for when and how to augment or switch treatment for MDD.

Leslie Citrome, MD, MPH Christoph U. Correll, MD Rakesh Jain, MD, MPH Roger McIntyre, MD, FRCPC Michael E. Thase, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: April 17, 2020 Expired: April 16, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Otsuka and Lundbeck Alliance

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue